ZNF324

gene
On this page

Also known as ZF5128ZNF324A

Summary

ZNF324 (zinc finger protein 324, HGNC:14096) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 324A (O75467). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within with a positive effect on G1/S transition of mitotic cell cycle and cell population proliferation. Predicted to be active in nucleus.

Source: NCBI Gene 25799 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 133 total
  • MANE Select transcript: NM_014347

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14096
Approved symbolZNF324
Namezinc finger protein 324
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesZF5128, ZNF324A
Ensembl geneENSG00000083812
Ensembl biotypeprotein_coding
OMIM617477
Entrez25799

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 11 protein_coding

ENST00000196482, ENST00000536459, ENST00000593925, ENST00000868897, ENST00000868898, ENST00000868899, ENST00000868900, ENST00000868901, ENST00000960633, ENST00000960634, ENST00000960635

RefSeq mRNA: 1 — MANE Select: NM_014347 NM_014347

CCDS: CCDS12981

Canonical transcript exons

ENST00000196482 — 4 exons

ExonStartEnd
ENSE000010055245846708058467183
ENSE000022497485847073158475436
ENSE000024374185846918058469306
ENSE000025027065846972858469844

Expression profiles

Bgee: expression breadth ubiquitous, 140 present calls, max score 81.21.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.4990 / max 118.9985, expressed in 1762 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1778476.76481751
1778480.7342444

Top tissues by expression

140 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534381.21gold quality
sural nerveUBERON:001548878.35gold quality
prefrontal cortexUBERON:000045178.31gold quality
stromal cell of endometriumCL:000225577.81gold quality
right lobe of liverUBERON:000111477.46gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.37gold quality
frontal cortexUBERON:000187077.00gold quality
granulocyteCL:000009476.67gold quality
superior frontal gyrusUBERON:000266176.09gold quality
ventricular zoneUBERON:000305375.97gold quality
right hemisphere of cerebellumUBERON:001489075.54gold quality
ganglionic eminenceUBERON:000402375.48gold quality
bloodUBERON:000017875.38gold quality
cerebellumUBERON:000203775.26gold quality
cerebellar hemisphereUBERON:000224575.22gold quality
cerebellar cortexUBERON:000212975.18gold quality
right frontal lobeUBERON:000281075.16gold quality
adenohypophysisUBERON:000219675.10gold quality
cerebral cortexUBERON:000095674.74gold quality
pituitary glandUBERON:000000774.60gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099174.28gold quality
Brodmann (1909) area 9UBERON:001354074.21gold quality
dorsolateral prefrontal cortexUBERON:000983474.09gold quality
bone marrowUBERON:000237174.08gold quality
urinary bladderUBERON:000125574.01gold quality
liverUBERON:000210773.85gold quality
left uterine tubeUBERON:000130373.71gold quality
mucosa of stomachUBERON:000119973.70gold quality
esophagus mucosaUBERON:000246973.68gold quality
skin of legUBERON:000151173.64gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.84

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1977.1ZNF324More than 3 adjacent zinc fingers
MA1977.2ZNF324More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:28273063

miRNA regulators (miRDB)

54 targeting ZNF324, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-9-5P100.0072.282361
HSA-MIR-3689D100.0066.141181
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-5193100.0067.261744
HSA-MIR-4682100.0068.891258
HSA-MIR-12118100.0065.881270
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-449399.9066.48977
HSA-MIR-7845-5P99.8864.88771
HSA-MIR-6857-5P99.8765.32985
HSA-MIR-477999.8666.501583
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-442899.7366.411733
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-128399.6972.423009
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-452799.6667.43714
HSA-MIR-320299.6667.702737
HSA-MIR-6503-5P99.6266.96597
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-6752-5P99.5967.321243
HSA-MIR-6751-5P99.5664.991145
HSA-MIR-4753-5P99.5468.511356
HSA-MIR-642A-5P99.5165.101152
HSA-MIR-6803-5P99.1963.901026
HSA-MIR-361-5P98.9570.161340

Literature-anchored findings (GeneRIF, showing 1)

  • Biological functions of miRNA-203b-3p/ZNF324 in laryngeal carcinoma. (PMID:38279443)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_rerio42sp43ENSDARG00000104170
mus_musculusZfp324ENSMUSG00000004500
rattus_norvegicusZfp324ENSRNOG00000027436
drosophila_melanogasterdwgFBGN0000520
drosophila_melanogasterCG6654FBGN0038301
caenorhabditis_elegansWBGENE00003933

Paralogs (6): ZBTB47 (ENSG00000114853), GTF3A (ENSG00000122034), ZUP1 (ENSG00000153975), ZNF513 (ENSG00000163795), ZNF652 (ENSG00000198740), ZNF324B (ENSG00000249471)

Protein

Protein identifiers

Zinc finger protein 324AO75467 (reviewed: O75467)

Alternative names: Zinc finger protein ZF5128

All UniProt accessions (2): O75467, M0R1C8

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation. May be involved in regulation of cell proliferation.

Subcellular location. Nucleus.

Tissue specificity. Expressed at high levels in the spleen, thymus, and PBMC, at low levels in the prostate, ovary, small intestine, colon (mucosal lining), placenta, lung, and pancreas, and very weakly expressed in the liver and kidney.

Induction. Induced at the early stage of T cell activation. Regulated at the transcriptional level during the cell cycle. Induced at a maximum level in the S phase.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_055162* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (14 total): zinc finger region 9, region of interest 2, chain 1, domain 1, short sequence motif 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75467-F164.680.39

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway
R-HSA-9843940Regulation of endogenous retroelements by KRAB-ZFP proteins

MSigDB gene sets: 71 (showing top): GOBP_CELL_CYCLE_PHASE_TRANSITION, ROVERSI_GLIOMA_COPY_NUMBER_UP, GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION, MODULE_123, GOBP_MITOTIC_CELL_CYCLE, GOBP_CELL_CYCLE_PROCESS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, CSR_EARLY_UP.V1_UP, ATM_DN.V1_UP, RELA_DN.V1_UP, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, PRC2_EZH2_UP.V1_UP, PRC2_SUZ12_UP.V1_UP, PDGF_ERK_DN.V1_DN

GO Biological Process (4): G1/S transition of mitotic cell cycle (GO:0000082), regulation of transcription by RNA polymerase II (GO:0006357), cell population proliferation (GO:0008283), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
RNA Polymerase II Transcription1
Regulation of endogenous retroelements1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
mitotic cell cycle1
mitotic cell cycle phase transition1
cell cycle G1/S phase transition1
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
cellular process1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

744 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF324TRIM28Q13263528
ZNF324ZNF382Q96SR6400
ZNF324ZNF224P17033399
ZNF324GSPT1P15170367
ZNF324GJD3Q8N144335
ZNF324CHERPQ8IWX8324
ZNF324ARHGAP25P42331306
ZNF324UBL3O95164298
ZNF324PHF3Q92576295
ZNF324ERHP70659290
ZNF324RNF26Q9BY78271
ZNF324RAP2CQ9Y3L5269
ZNF324NFRKBQ6P4R8256
ZNF324CLIC3O95833249
ZNF324MGST3O14880244

IntAct

58 interactions, top by confidence:

ABTypeScore
ZNF169ZNF316psi-mi:“MI:0914”(association)0.530
ZNF324BZNF316psi-mi:“MI:0914”(association)0.530
ZNF707ZNF316psi-mi:“MI:0914”(association)0.530
VWCEZNF316psi-mi:“MI:0914”(association)0.530
CACNG5ZNF316psi-mi:“MI:0914”(association)0.530
PRG3ZNF324psi-mi:“MI:0914”(association)0.530
RPF1ZNF324psi-mi:“MI:0914”(association)0.530
TRIM28ZNF316psi-mi:“MI:0914”(association)0.530
FBLZNF316psi-mi:“MI:0914”(association)0.530
ZNF764SH3PXD2Bpsi-mi:“MI:0914”(association)0.530
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
ZNF324BZNF324psi-mi:“MI:0914”(association)0.530
ZNF460ZNF324psi-mi:“MI:0914”(association)0.530
NOTCH2ZNF316psi-mi:“MI:0914”(association)0.530
Trim28FTH1psi-mi:“MI:0915”(physical association)0.400
ZNF324RPL4psi-mi:“MI:0915”(physical association)0.400
FBLGXYLT2psi-mi:“MI:0914”(association)0.350
NXF2BMEIOCpsi-mi:“MI:0914”(association)0.350
RFPL4BKRBA1psi-mi:“MI:0914”(association)0.350
EFEMP1ZNF316psi-mi:“MI:0914”(association)0.350
PSME3ZNF891psi-mi:“MI:0914”(association)0.350
SKAP1MYO9Apsi-mi:“MI:0914”(association)0.350

BioGRID (69): ZNF324 (Affinity Capture-RNA), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS)

ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2

Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

133 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance114
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

973 predictions. Top by Δscore:

VariantEffectΔscore
19:58467181:A:Tdonor_gain1.0000
19:58469176:TTA:Tacceptor_loss1.0000
19:58469177:TA:Tacceptor_loss1.0000
19:58469178:A:AGacceptor_gain1.0000
19:58469178:AG:Aacceptor_gain1.0000
19:58469178:AGGA:Aacceptor_loss1.0000
19:58469179:G:GTacceptor_gain1.0000
19:58469179:GG:Gacceptor_gain1.0000
19:58469179:GGACC:Gacceptor_gain1.0000
19:58469302:GCTGG:Gdonor_gain1.0000
19:58469304:TGGG:Tdonor_loss1.0000
19:58469305:GG:Gdonor_gain1.0000
19:58469306:GG:Gdonor_gain1.0000
19:58469306:GGT:Gdonor_loss1.0000
19:58469307:G:Cdonor_loss1.0000
19:58469307:G:GGdonor_gain1.0000
19:58469308:T:Gdonor_loss1.0000
19:58469723:CACAG:Cacceptor_loss1.0000
19:58469724:ACAG:Aacceptor_gain1.0000
19:58469726:A:AGacceptor_gain1.0000
19:58469726:A:ATacceptor_loss1.0000
19:58469726:AG:Aacceptor_gain1.0000
19:58469727:G:GAacceptor_gain1.0000
19:58469727:GG:Gacceptor_gain1.0000
19:58469727:GGA:Gacceptor_gain1.0000
19:58469727:GGAC:Gacceptor_gain1.0000
19:58469727:GGACT:Gacceptor_gain1.0000
19:58469831:G:GTdonor_gain1.0000
19:58469842:CTGG:Cdonor_loss1.0000
19:58469845:G:GGdonor_gain1.0000

AlphaMissense

3579 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:58471372:T:CF294L1.000
19:58471374:C:AF294L1.000
19:58471374:C:GF294L1.000
19:58471288:T:CF266L0.999
19:58471290:C:AF266L0.999
19:58471290:C:GF266L0.999
19:58471456:T:CF322L0.999
19:58471458:C:AF322L0.999
19:58471458:C:GF322L0.999
19:58471540:T:CF350L0.999
19:58471542:C:AF350L0.999
19:58471542:C:GF350L0.999
19:58471624:T:CF378L0.999
19:58471626:C:AF378L0.999
19:58471626:C:GF378L0.999
19:58471708:T:CF406L0.999
19:58471710:C:AF406L0.999
19:58471710:C:GF406L0.999
19:58471792:T:CF434L0.999
19:58471794:T:AF434L0.999
19:58471794:T:GF434L0.999
19:58471876:T:CF462L0.999
19:58471878:C:AF462L0.999
19:58471878:C:GF462L0.999
19:58471960:T:CF490L0.999
19:58471962:C:AF490L0.999
19:58471962:C:GF490L0.999
19:58471307:T:CL272P0.998
19:58471317:C:AH275Q0.998
19:58471317:C:GH275Q0.998

dbSNP variants (sampled 300 via entrez): RS1000430399 (19:58475937 G>A,C), RS1000441917 (19:58467921 C>T), RS1000787520 (19:58472452 A>G), RS1000955127 (19:58472706 A>T), RS1001156533 (19:58468776 C>T), RS1001498615 (19:58467374 C>A,G,T), RS1001551015 (19:58467533 C>G,T), RS1001678933 (19:58468197 G>A), RS1001897208 (19:58475613 T>C), RS1001950987 (19:58475784 G>A,C), RS1002062748 (19:58471829 T>G), RS1002451723 (19:58472501 G>T), RS1002603678 (19:58473941 C>T), RS1003001846 (19:58470766 G>A,C), RS1003119416 (19:58470595 C>A,T)

Disease associations

OMIM: gene MIM:617477 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1increases expression, increases methylation2
aristolochic acid Iincreases expression1
TAK-243increases sumoylation1
bisphenol Aaffects cotreatment, decreases expression1
trichostatin Aaffects expression1
ferrous chloridedecreases expression1
cupric oxideincreases expression1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
abrineincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Sunitinibincreases expression1
Arsenicaffects methylation1
Dexamethasoneaffects cotreatment, decreases expression1
Diazinonincreases methylation1
Ethyl Methanesulfonateincreases expression1
Indomethacinaffects cotreatment, decreases expression1
Methyl Methanesulfonateincreases expression1
Seleniumaffects cotreatment, increases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Valproic Acidincreases methylation1
Vitamin Eaffects cotreatment, increases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, decreases expression1
Asbestos, Crocidolitedecreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_HD20HEK293 eGFP-ZNF324Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.